Adicet Bio, Inc. (ACET)

Latest Insider Confidence Score

2026Q1

55.7
Bullish

Company insider confidence (by quarter)

2018Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Orbimed Advisors Llc 10% Owner 2,930,527 Oct 10, 2025
OrbiMed Advisors Israel II Ltd 10% Owner 2,930,527 Oct 10, 2025
OrbiMed Israel GP II, L.P. 10% Owner 2,930,527 Oct 10, 2025
OrbiMed Genesis GP LLC 10% Owner 2,930,527 Oct 10, 2025
OrbiMed Capital GP V LLC 10% Owner 2,930,527 Oct 10, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 24, 2026 Jan 27, 2026 Aftab Blake Chief Scientific Officer Sell 47.5 -535 -15.22% ✗ $4.5K
Jan 24, 2026 Jan 27, 2026 Healey Don Chief Technology Officer Sell 47.5 -535 -13.42% ✗ $4.5K
Jan 24, 2026 Jan 27, 2026 Schor Chen CEO Sell 46.3 -1,755 -12.00% ✗ $14.8K
Jan 24, 2026 Jan 27, 2026 Harvey Brian Nicholas CFO Sell 47.5 -546 -9.59% ✗ $4.6K
Oct 8, 2025 Oct 10, 2025 ORBIMED ADVISORS LLC 10% Owner Buy 100.0 +5,000,000 58.71% ✗ $5M
Jun 11, 2025 Jun 13, 2025 Klickstein Lloyd Director Neutral 85.0 +5,900 5.75% ✗ -
Jun 11, 2025 Jun 13, 2025 Chodakewitz Jeffrey Director Neutral 90.0 +5,900 50.00% ✗ -
Jun 11, 2025 Jun 13, 2025 DUBIN STEVE Director Neutral 90.0 +5,900 35.12% ✗ -
Jun 11, 2025 Jun 13, 2025 Peng Katie Director Neutral 90.0 +5,900 100.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Sinclair Andrew Director Neutral 90.0 +5,900 50.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Grissinger Michael Director Neutral 52.5 - 0.00% ✗ -
Apr 21, 2025 Grissinger Michael Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 4, 2025 Aftab Blake Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 4, 2025 Schor Chen CEO Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 4, 2025 Healey Don Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 4, 2025 Maltzman Julia D. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 4, 2025 Harvey Brian Nicholas CFO Neutral 52.5 - 0.00% ✗ -
Jan 24, 2025 Jan 28, 2025 Schor Chen CEO Sell 46.3 -28,101 -10.72% ✗ $25.9K
Jan 24, 2025 Jan 28, 2025 Healey Don Chief Technology Officer Sell 47.5 -8,560 -11.83% ✗ $7.9K
Jan 24, 2025 Jan 28, 2025 Aftab Blake Chief Scientific Officer Sell 47.5 -6,270 -10.03% ✗ $5.8K
Jan 24, 2025 Jan 28, 2025 Harvey Brian Nicholas CFO Sell 47.5 -8,752 -8.77% ✗ $8.1K
Jan 23, 2025 Maltzman Julia D. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Aug 21, 2024 Aug 23, 2024 Sinclair Andrew Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2024 Aug 23, 2024 GORDON CARL L Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2024 Aug 23, 2024 Peng Katie Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2024 Aug 23, 2024 Chodakewitz Jeffrey Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2024 Aug 23, 2024 DUBIN STEVE Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2024 Aug 23, 2024 Kauffman Michael Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2024 Aug 23, 2024 Jakobovits Aya Director Neutral 52.5 - 0.00% ✗ -
Aug 19, 2024 Aug 20, 2024 Klickstein Lloyd Director Neutral 52.5 - 0.00% ✗ -
Aug 20, 2024 Klickstein Lloyd Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Aftab Blake Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Galimi Francesco SVP & Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Harvey Brian Nicholas CFO Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Healey Don Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Schor Chen CEO Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 7, 2024 GORDON CARL L Director Neutral 55.0 +5,900 0.05% ✗ -
Jun 5, 2024 Jun 7, 2024 Chodakewitz Jeffrey Director Neutral 90.0 +5,900 100.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Jakobovits Aya Director Neutral 67.5 +5,900 0.69% ✗ -
Jun 5, 2024 Jun 7, 2024 DUBIN STEVE Director Neutral 90.0 +5,900 54.13% ✗ -
Jun 5, 2024 Jun 7, 2024 Kauffman Michael Director Sell 52.5 - 0.00% ✗ $8.4K
Jun 5, 2024 Jun 7, 2024 Peng Katie Director Neutral 90.0 +5,900 100.00% ✗ -
Jun 5, 2024 Jun 7, 2024 Sinclair Andrew Director Neutral 90.0 +5,900 100.00% ✗ -
Jan 25, 2024 Jan 26, 2024 ORBIMED ADVISORS LLC Director Buy 100.0 +3,125,000 47.01% ✗ $7.5M
Jan 25, 2024 Jan 26, 2024 GORDON CARL L Director Buy 100.0 +3,125,000 47.01% ✗ $7.5M
Jan 24, 2024 Jan 26, 2024 Galimi Francesco SVP & Chief Medical Officer Sell 91.3 +21,343 26.53% ✗ $11.9K
Jan 24, 2024 Jan 26, 2024 Aftab Blake Chief Scientific Officer Sell 90.0 +16,135 34.79% ✗ $8.6K
Jan 24, 2024 Jan 26, 2024 Healey Don Chief Technology Officer Sell 91.3 +14,830 25.79% ✗ $11.7K
Jan 24, 2024 Jan 26, 2024 Harvey Brian Nicholas CFO Sell 91.3 +21,980 28.24% ✗ $10.4K
Jan 24, 2024 Jan 26, 2024 Schor Chen CEO Sell 91.3 +55,010 21.95% ✗ $36.7K
Oct 12, 2023 Oct 16, 2023 Aftab Blake Chief Scientific Officer Sell 46.3 -7,933 -14.61% ✗ $10.7K
Oct 2, 2023 Oct 3, 2023 Galimi Francesco SVP & Chief Medical Officer Sell 46.3 -8,093 -9.14% ✗ $11.1K
Oct 2, 2023 Oct 3, 2023 Healey Don Chief Technology Officer Sell 46.3 -9,069 -13.62% ✗ $12.4K
Oct 2, 2023 Oct 3, 2023 Harvey Brian Nicholas CFO Sell 47.5 -7,096 -8.36% ✗ $9.7K
Sep 28, 2023 Oct 2, 2023 Schor Chen CEO Sell 46.3 -23,208 -10.53% ✗ $31.9K
Aug 14, 2023 Aug 16, 2023 Schor Chen CEO Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Galimi Francesco SVP & Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Aftab Blake Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Harvey Brian Nicholas CFO Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Healey Don Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 GORDON CARL L Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Sanna Bastiano Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Sinclair Andrew Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Kauffman Michael Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 DUBIN STEVE Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Jakobovits Aya Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Chodakewitz Jeffrey Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2023 Aug 16, 2023 Peng Katie Director Neutral 52.5 - 0.00% ✗ -
Jul 10, 2023 Jul 11, 2023 Peng Katie Director Neutral 52.5 - 0.00% ✗ -
Jul 11, 2023 Peng Katie Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2023 Jun 30, 2023 DUBIN STEVE Director Buy 91.3 +5,000 84.75% ✗ $12K
Jun 27, 2023 Jun 29, 2023 GORDON CARL L Director Buy 100.0 +875,000 12.10% ✗ $1.8M
Jun 27, 2023 Jun 29, 2023 ORBIMED ADVISORS LLC Director Buy 100.0 +875,000 12.10% ✗ $1.8M
Jun 1, 2023 Jun 2, 2023 Chodakewitz Jeffrey Director Neutral 90.0 +5,900 100.00% ✗ -
Jun 1, 2023 Jun 2, 2023 Sanna Bastiano Director Neutral 90.0 +5,900 100.00% ✗ -
Jun 1, 2023 Jun 2, 2023 Kauffman Michael Director Neutral 90.0 +5,900 100.00% ✗ -
Jun 1, 2023 Jun 2, 2023 Jakobovits Aya Director Neutral 67.5 +5,900 0.69% ✗ -
Jun 1, 2023 Jun 2, 2023 GORDON CARL L Director Neutral 90.0 +5,900 100.00% ✗ -
Jun 1, 2023 Jun 2, 2023 DUBIN STEVE Director Neutral 90.0 +5,900 100.00% ✗ -
Jun 1, 2023 Jun 2, 2023 Sinclair Andrew Director Neutral 60.0 +5,900 0.28% ✗ -
Feb 15, 2023 Feb 17, 2023 Healey Don Chief Technology Officer Sell 36.3 -4,533 -6.38% ✓ $34.3K
Sep 13, 2022 Feb 14, 2023 Schor Chen CEO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2023 Feb 14, 2023 Healey Don Chief Technology Officer Sell 25.0 -10,467 -12.83% ✓ $83.5K
Jan 24, 2023 Jan 26, 2023 Galimi Francesco SVP & Chief Medical Officer Neutral 90.0 +26,100 41.79% ✗ -
Jan 24, 2023 Jan 26, 2023 Harvey Brian Nicholas CFO Neutral 90.0 +26,100 44.38% ✗ -
Jan 24, 2023 Jan 26, 2023 Healey Don Chief Technology Officer Neutral 90.0 +26,100 47.05% ✗ -
Jan 24, 2023 Jan 26, 2023 Aftab Blake Chief Scientific Officer Neutral 90.0 +26,100 92.52% ✗ -
Jan 24, 2023 Jan 26, 2023 Schor Chen CEO Neutral 90.0 +85,500 59.01% ✗ -
Nov 10, 2022 Nov 15, 2022 Aftab Blake Chief Scientific Officer Sell 20.0 -6,967 -19.81% ✓ $146.3K
Nov 10, 2022 Nov 15, 2022 Schor Chen CEO Sell 12.5 -39,955 -21.62% ✓ $811.2K
Nov 7, 2022 Nov 9, 2022 Schor Chen CEO Sell 22.5 -30,000 -13.96% ✓ $571.5K
Nov 2, 2022 Nov 4, 2022 Schor Chen CEO Sell 22.5 -25,313 -10.54% ✓ $456.7K
Oct 19, 2022 Oct 21, 2022 Aftab Blake Chief Scientific Officer Sell 20.0 -8,067 -18.66% ✓ $131.3K
Oct 12, 2022 Oct 14, 2022 Aftab Blake Chief Scientific Officer Sell 20.0 -9,579 -18.13% ✓ $151.6K
Oct 4, 2022 Oct 4, 2022 Schor Chen CEO Sell 40.0 -21,288 -8.14% ✗ $302.7K
Oct 4, 2022 Oct 4, 2022 Harvey Brian Nicholas CFO Sell 42.5 -7,096 -10.77% ✗ $100.9K
Oct 4, 2022 Oct 4, 2022 Healey Don Chief Technology Officer Sell 42.5 -7,933 -12.51% ✗ $112.8K
Oct 4, 2022 Oct 4, 2022 Galimi Francesco SVP & Chief Medical Officer Sell 42.5 -7,933 -11.27% ✗ $112.8K
Sep 14, 2022 Sep 16, 2022 Schor Chen CEO Sell 52.5 -952 -0.36% ✓ $17.1K
Sep 9, 2022 Sep 13, 2022 Schor Chen CEO Sell 20.0 -78,412 -14.24% ✓ $1.3M